» Articles » PMID: 37426784

MiR-92a and Integrin Expression in Fibrovascular Membranes in Proliferative Diabetic Retinopathy

Overview
Specialty Ophthalmology
Date 2023 Jul 10
PMID 37426784
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic retinopathy (DR) is a leading cause of vision impairment. The proliferative form of DR (PDR) involves fibrovascular membrane (FVM) formation at the vitreoretinal interface. MicroRNAs (miRNAs) are a class of non-coding RNA molecules that play an important role in gene regulation; a single miRNA could regulate multiple genes. We previously reported that miR-92a, a suppressor of integrins α and α, was downregulated in DR. Considering the integrin's role in FVM pathology and the potential involvement of miR-92a in DR, we asked a question whether miR-92a could play a critical role in FVM pathology. We collected the FVM and epiretinal membranes of individuals with PDR and macular pucker (control) undergoing pars plana vitrectomy. The frozen sections of membranes were stained for α and αβ integrins. The miR-92a levels were assessed using real-time quantitative PCR. The FVMs of individuals with PDR stained brighter for integrin subunits α and αβ compared to the epiretinal membranes of subjects with macular pucker. miR-92a levels were decreased in FVM subjects. In conclusion, our studies demonstrate that miR-92a decrease is associated with an increase in integrins α and αβ, thus contributing to the inflammatory milieu in PDR.

Citing Articles

Transcriptomic Profile of LinSca1c-kit (LSK) cells in db/db mice with long-standing diabetes.

Mahajan N, Luo Q, Abhyankar S, Bhatwadekar A BMC Genomics. 2024; 25(1):782.

PMID: 39134978 PMC: 11318115. DOI: 10.1186/s12864-024-10679-3.

References
1.
Luna J, Tobe T, Mousa S, Reilly T, Campochiaro P . Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. Lab Invest. 1996; 75(4):563-73. View

2.
Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan S . Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci. 1987; 28(3):506-14. View

3.
Wilkinson-Berka J, Jones D, Taylor G, Jaworski K, Kelly D, Ludbrook S . SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2006; 47(4):1600-5. DOI: 10.1167/iovs.05-1314. View

4.
Preissner K, Kanse S, Hammes H . Integrin chatter and vascular function in diabetic retinopathy. Horm Metab Res. 1998; 29(12):643-5. DOI: 10.1055/s-2007-979118. View

5.
Kovacs B, Lumayag S, Cowan C, Xu S . MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci. 2011; 52(7):4402-9. DOI: 10.1167/iovs.10-6879. View